These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27518755)

  • 1. Method validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.
    Comiran E; Barreto F; Meneghini LZ; Carlos G; Fröehlich PE; Limberger RP
    Biomed Chromatogr; 2017 Mar; 31(3):. PubMed ID: 27518755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine.
    Comiran E; Carlos G; Barreto F; Pechanksy F; Fröehlich PE; Limberger RP
    Biopharm Drug Dispos; 2021 Jan; 42(1):3-11. PubMed ID: 33119133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of methylphenidate, ethylphenidate, lisdexamfetamine, and amphetamine in oral fluid by liquid chromatography-tandem mass spectrometry.
    Smith CR; Swortwood MJ
    J Forensic Sci; 2022 Mar; 67(2):669-675. PubMed ID: 34985135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of lisdexamfetamine and its metabolite d-amphetamine in urine and gastric contents collected from a cadaver at forensic autopsy.
    Torimitsu S; Saka K; Noritake K; Namera A; Makino Y; Yamaguchi R; Iwase H
    Forensic Toxicol; 2023 Jul; 41(2):309-317. PubMed ID: 36562920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Infant with a Prolonged Sympathomimetic Toxidrome after Lisdexamfetamine Dimesylate Ingestion.
    Wood KE; Krasowski MD
    J Med Toxicol; 2016 Dec; 12(4):402-405. PubMed ID: 27277955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.
    Boellner SW; Stark JG; Krishnan S; Zhang Y
    Clin Ther; 2010 Feb; 32(2):252-64. PubMed ID: 20206783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral analysis of amphetamines in hair by liquid chromatography-tandem mass spectrometry: compliance-monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse® therapy and identification after controlled low-dose application.
    Binz TM; Williner E; Strajhar P; Dolder PC; Liechti ME; Baumgartner MR; Kraemer T; Steuer AE
    Drug Test Anal; 2018 Feb; 10(2):254-261. PubMed ID: 28440070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisdexamfetamine: A pharmacokinetic review.
    Comiran E; Kessler FH; Fröehlich PE; Limberger RP
    Eur J Pharm Sci; 2016 Jun; 89():172-9. PubMed ID: 27125257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy.
    Ermer JC; Pennick M; Frick G
    Clin Drug Investig; 2016 May; 36(5):341-56. PubMed ID: 27021968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
    Krishnan SM; Pennick M; Stark JG
    Clin Drug Investig; 2008; 28(12):745-55. PubMed ID: 18991468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Analysis of Amphetamine Stimulants in a Whole Urine Sample by Atmospheric Solids Analysis Probe Tandem Mass Spectrometry.
    Crevelin EJ; Salami FH; Alves MN; De Martinis BS; Crotti AE; Moraes LA
    J Am Soc Mass Spectrom; 2016 May; 27(5):944-7. PubMed ID: 26907179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
    Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
    Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine.
    Haedener M; Weinmann W; Eich D; Liebrenz M; Wuethrich T; Buadze A
    PLoS One; 2021; 16(3):e0248747. PubMed ID: 33784320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.
    Ward K; Citrome L
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):229-238. PubMed ID: 29258368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donors.
    Pennick M
    J Drug Assess; 2013; 2(1):17-20. PubMed ID: 27536433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
    Fisher DS; Partridge SJ; Handley SA; Couchman L; Morgan PE; Flanagan RJ
    Forensic Sci Int; 2013 Jun; 229(1-3):145-50. PubMed ID: 23477803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds.
    Gao S; Meng L; Zhao C; Zhang T; Qiu P; Zhang F
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomer-specific analysis of amphetamine in urine, oral fluid and blood.
    Bakke E; Nilsen Terland M; Strand DH; Øiestad EL; Høiseth G
    J Anal Toxicol; 2024 Jun; 48(5):254-262. PubMed ID: 38706158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of lisdexamfetamine dimesylate stability and identification of its degradation product by NMR spectroscopy.
    Carlos G; Magalhães A; Isler AC; Comiran E; Fröehlich PE
    Drug Dev Ind Pharm; 2019 Jan; 45(1):139-146. PubMed ID: 30231652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.